Wednesday - January 16, 2019
Long Island Resident With Recurrent Brain Cancer Receives Novel Experimental Treatment at Lenox Hill Hospital
January 11, 2018
GREAT NECK, New York, Jan. 11 -- Northwell Health (formerly the North Shore-LIJ Health System) issued the following news release:

Daniel Levitt, 38, from Sayville, Long Island, was one of the early patients in the United States to be enrolled in a Phase I clinical trial for one of the most aggressive forms of brain cancer - glioblastoma multiforme (GBM). The clinical trial being conducted at Lenox Hill Hospital is testing the safety and efficacy of a new targeted nanocell therapy wh . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

What's your
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products